Mechanics Bank Trust Department lifted its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 560.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,209 shares of the medical technology company’s stock after acquiring an additional 5,269 shares during the period. Mechanics Bank Trust Department’s holdings in Stryker were worth $1,894,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in SYK. Quarry LP bought a new stake in Stryker during the first quarter worth $27,000. Freedom Wealth Alliance LLC bought a new stake in Stryker during the fourth quarter worth $26,000. Altshuler Shaham Ltd bought a new stake in Stryker during the first quarter worth $33,000. HBW Advisory Services LLC bought a new stake in Stryker during the second quarter worth $35,000. Finally, Cascade Investment Advisors Inc. bought a new stake in Stryker during the first quarter worth $34,000. Institutional investors own 76.24% of the company’s stock.
In other news, insider Viju Menon sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $289.00, for a total value of $1,445,000.00. Following the completion of the sale, the insider now directly owns 6,994 shares in the company, valued at approximately $2,021,266. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 5.90% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Stryker Stock Performance
Shares of Stryker stock opened at $292.77 on Friday. The company has a current ratio of 1.54, a quick ratio of 0.84 and a debt-to-equity ratio of 0.64. The business has a 50-day moving average price of $286.90 and a two-hundred day moving average price of $285.73. Stryker Co. has a 1-year low of $200.80 and a 1-year high of $306.93. The company has a market cap of $111.19 billion, a P/E ratio of 41.35, a PEG ratio of 2.85 and a beta of 0.95.
Stryker (NYSE:SYK – Get Free Report) last issued its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.54 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.16. Stryker had a return on equity of 22.31% and a net margin of 13.92%. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.83 billion. During the same period last year, the business posted $2.25 EPS. The business’s revenue was up 11.2% compared to the same quarter last year. As a group, analysts anticipate that Stryker Co. will post 10.37 EPS for the current year.
Stryker Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, September 28th. This represents a $3.00 dividend on an annualized basis and a yield of 1.02%. Stryker’s payout ratio is currently 42.37%.
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.
- Five stocks we like better than Stryker
- Conference Calls and Individual Investors
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- MarketBeat Week in Review – 9/11 – 9/15
- What is the Hang Seng index?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.